Position in TPST
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8
-$48 QoQ
Shares Held
5
-16.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TPST Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,940,254,192 across 425 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in TPST
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8 | 5 | Shares | Defined | 2026-05-13 | |
| 2025-03-31 | $56 | 77 | Shares | Defined | 2025-05-12 | |
| 2023-12-31 | $483 | 110 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $1 | 6 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $726 | 313 | Shares | Defined | 2023-05-18 | |
| 2022-03-31 | $446 | 132 | Shares | Defined | 2022-05-11 | |
| 2021-06-30 | $111 | 10 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||